Tecan Genomics, Inc. v. Invitae Corporation
1:23-cv-01114
Overview
Parties
Defendant
Integrated DNA Technologies, Inc. NPE (Patent Assertion Entity)
Represented By
6 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
ArcherDX, LLC Operating Company
Represented By
6 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Invitae Corporation NPE (Individual / Inventor)
Represented By
6 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Plaintiff
Tecan Genomics, Inc. Operating Company
Represented By
7 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
QIAGEN Sciences, LLC v. Tecan Group AG
QIAGEN Sciences, LLC v. Tecan Group AG
QIAGEN Sciences, LLC v. Tecan Group AG
Integrated DNA Technologies, Inc. et al. v. Tecan Group AG
Integrated DNA Technologies, Inc. et al. v. Tecan Group AG
Integrated DNA Technologies, Inc. et al. v. Tecan Group AG
Integrated DNA Technologies, Inc. et al. v. Tecan Group AG
Patents Involved
There are 5 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US10036012
Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
|
Filed: 2017-03-28
Issued: 2018-07-31
|
Active (10.3 yrs remaining)
Expires: 2037-03-28
|
|
|
US10876108
Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
|
Filed: 2018-06-25
Issued: 2020-12-29
|
Active (6.7 yrs remaining)
Expires: 2033-08-16
|
|
|
US9546399
Compositions and methods for identification of a duplicate sequencing read
|
Filed: 2014-11-13
Issued: 2017-01-17
|
Active (8.0 yrs remaining)
Expires: 2034-11-13
|
|
|
US11098357
Compositions and methods for identification of a duplicate sequencing read
|
Filed: 2020-01-15
Issued: 2021-08-24
|
Active (13.1 yrs remaining)
Expires: 2040-01-15
|
|
|
US11725241
Compositions and methods for identification of a duplicate sequencing read
|
Filed: 2021-07-21
Issued: 2023-08-15
|
Active (8.5 yrs remaining)
Expires: 2035-05-19
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
34
Dispositive
6
Granted
0
Denied
0
Pending / Review
21
Motions by Category
Key Dispositive Motions & Rulings